Shopping Cart 0
Cart Subtotal
USD 0

Genomic Health Inc (GHDX)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Genomic Health Inc (GHDX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genomic Health Inc (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It perform extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in the US, Europe, and Asia through its subsidiaries and offices. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc Key Recent Developments

Feb 14,2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook

Nov 01,2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results

Sep 28,2016: Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress

Aug 02,2016: Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance

May 04,2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Genomic Health Inc-Key Facts 6

Genomic Health Inc-Key Employees 7

Genomic Health Inc-Key Employee Biographies 8

Genomic Health Inc-Major Products and Services 10

Genomic Health Inc-Medical Equipment Pipeline Products Data 11

Genomic Health Inc Pipeline Products by Equipment Type 11

Genomic Health Inc Pipeline Products by Development Stage 12

Genomic Health Inc-History 14

Genomic Health Inc-Company Statement 16

Genomic Health Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 19

Genomic Health Inc-Business Description 19

Genomic Health Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Genomic Health Inc-Strengths 20

Genomic Health Inc-Weaknesses 21

Genomic Health Inc-Opportunities 22

Genomic Health Inc-Threats 23

Genomic Health Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 32

Genomic Health Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 33

Genomic Health Inc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 35

Nov 01, 2016: Genomic Health Reports Third Consecutive Quarter of Double-Digit Revenue Growth in Announcement of Third Quarter 2016 Financial Results 37

Sep 28, 2016: Genomic Health Reinforces Global Leadership in Genomic-based Diagnostics with Presentation of Nine Personalized Medicine Studies Conducted in Six Countries at ESMO 2016 Congress 39

Aug 02, 2016: Genomic Health Reports Continued Double-Digit Growth in Announcement of Second Quarter 2016 Financial Results, Raises Low End of Full-Year Test and Revenue Guidance 42

May 04, 2016: Genomic Health Reports Double-Digit Revenue and Test Growth in Announcement of First Quarter 2016 Financial Results 44

Mar 11, 2016: Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX in Node-positive and High-risk Node-negative Breast Cancer 45

Mar 09, 2016: German National Cancer Guidelines Distinguish Oncotype DX as First and Only Multi-gene Breast Cancer Test with 1A Level of Evidence 47

Mar 01, 2016: Journal of Clinical Oncology Publishes Prospective Outcomes Results from Large International Trial Using Oncotype DX 48

Feb 10, 2016: Genomic Health Announces 2016 Financial Outlook and Provides 2015 Fourth Quarter and Year-End Financial Results 49

Jan 11, 2016: Genomic Health Announces Plans to Launch Liquid Biopsy Mutation Panel in 2016 51

Section 6-Appendix 52

Methodology 52

Ratio Definitions 52

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

Genomic Health Inc Pipeline Products by Equipment Type 11

Genomic Health Inc Pipeline Products by Development Stage 12

Genomic Health Inc, Performance Chart (2012-2016) 29

Genomic Health Inc, Ratio Charts 31

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 32

Genomic Health Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 33


List Of Table

List of Tables

Genomic Health Inc, Key Facts 6

Genomic Health Inc, Key Employees 7

Genomic Health Inc, Key Employee Biographies 8

Genomic Health Inc, Major Products and Services 10

Genomic Health Inc Pipeline Products by Equipment Type 11

Genomic Health Inc Number of Pipeline Products by Development Stage 12

Genomic Health Inc Pipeline Products Summary by Development Stage 13

Genomic Health Inc, History 14

Genomic Health Inc, Other Locations 18

Genomic Health Inc, Subsidiaries 18

Genomic Health Inc, Key Competitors 24

Genomic Health Inc, Ratios based on current share price 25

Genomic Health Inc, Annual Ratios 26

Genomic Health Inc, Annual Ratios (Cont...1) 27

Genomic Health Inc, Annual Ratios (Cont...2) 28

Genomic Health Inc, Interim Ratios 30

Genomic Health Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 32

Genomic Health Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 33

Genomic Health Inc, Recent Deals Summary 34

Currency Codes 52

Capital Market Ratios 52

Equity Ratios 53

Profitability Ratios 53

Cost Ratios 54

Liquidity Ratios 54

Leverage Ratios 55

Efficiency Ratios 55

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Siemens AG Response Genetics Inc Qiagen NV Novartis AG NanoString Technologies Inc Myriad Genetics Inc Hologic Inc GE Healthcare Ltd